2,6-Diaminopurine-9-Arabinoside Bulk Price Quotation 2026
- Market Stability: 2026 projections indicate stable raw material costs for nucleoside analogs despite global supply chain adjustments.
- Purity Standards: Industrial grade material typically exceeds 98% purity, with HPLC validation required for pharmaceutical intermediates.
- Procurement Strategy: Volume-based tiering significantly reduces unit costs for multi-kilogram contracts.
The pharmaceutical landscape for nucleoside analogs continues to evolve, with CAS 34079-68-0 remaining a critical intermediate for antiviral and oncology research. As we approach 2026, procurement managers must navigate complex variables influencing the bulk price of this specialized compound. Understanding the technical nuances of the manufacturing process is essential for securing favorable terms and ensuring supply chain reliability. NINGBO INNO PHARMCHEM CO.,LTD. stands as a premier global manufacturer offering these technical advantages and bulk supply capabilities to international partners.
This compound, chemically defined as C10H14N6O4 with a molecular weight of 282.26 g/mol, requires precise glycosylation conditions to maintain stereochemical integrity. The market demand is driven by its utility in synthesizing complex nucleotide derivatives. Buyers focusing solely on headline pricing often overlook the critical impact of industrial purity specifications on downstream reaction yields. Impurities at the nucleobase or sugar moiety can catalyze degradation during subsequent coupling steps, leading to significant losses in overall process efficiency.
Factors Influencing Bulk Pricing
The cost structure for 2,6-Diaminopurine-9-arabinoside is not linear; it is heavily dependent on the sophistication of the synthesis route employed by the producer. Traditional methods involving direct coupling of 2,6-diaminopurine with protected arabinose derivatives often require extensive purification steps to remove alpha-anomers. Advanced enzymatic or chemo-enzymatic pathways can improve beta-selectivity but may incur higher initial biocatalyst costs. These technical choices directly correlate with the final quotation provided to bulk buyers.
Raw material volatility is another primary driver. The availability of high-quality protected sugars and purine bases fluctuates based on upstream petrochemical pricing and regional manufacturing capacity. Furthermore, regulatory compliance costs, including environmental waste disposal for solvent-heavy processes, are increasingly factored into the final unit price. A reputable global manufacturer will transparently account for these compliance costs rather than hiding them in variable surcharges. Buyers should request detailed breakdowns regarding solvent recovery rates and crystallization efficiencies, as these metrics often distinguish premium suppliers from commodity traders.
Storage and logistics also play a pivotal role in cost calculation. With a recommended storage temperature of 2-8°C, cold chain logistics are mandatory for maintaining product stability during transit. Ambient shipping conditions may be permissible for short durations, but long-term exposure to heat can degrade the glycosidic bond. Consequently, quotations for international shipments must include insulated packaging and expedited freight options to ensure the material arrives within specification. Failure to account for these logistical requirements can result in rejected shipments and costly disputes.
Volume Discount Structures
Procurement strategies for 2026 should leverage tiered pricing models inherent to chemical manufacturing. Most producers offer significant margin improvements when orders transition from gram-scale research quantities to kilogram or metric ton scales. For 2,6-Diamino-9-(β-D-arabinofuranosyl)purine, the economies of scale are realized through batch optimization. Running larger reactors reduces the relative cost of labor, quality control testing, and equipment setup time per unit of output.
Typical discount structures may offer 10-15% reductions for orders exceeding 50 kilograms, with further negotiations available for annual supply agreements. Locking in pricing through forward contracts can protect buyers from market spikes caused by raw material shortages. It is advisable to discuss flexible delivery schedules where inventory is held by the manufacturer and released in batches. This approach minimizes the buyer's storage costs while ensuring the material remains within its stability window. Additionally, consolidated shipping for multiple intermediates can further reduce landed costs.
Requesting Custom Quotes and Technical Documentation
Securing an accurate quotation requires precise specification of quality parameters. Standard commercial grades may suffice for early-stage research, but GMP-adjacent projects demand rigorous documentation. When sourcing high-purity 6-Diamino-9-(β-D-arabinofuranosyl)purine, buyers should explicitly request a comprehensive Certificate of Analysis (COA). This document must detail HPLC purity profiles, residual solvent analysis, and heavy metal content. A robust COA is not merely a formality; it is a critical quality assurance tool that validates the synthesis route and purification efficacy.
Custom synthesis options are often available for clients requiring specific isotopic labeling or alternative salt forms. These requests should be initiated early in the procurement cycle to allow for process development time. Communication regarding packaging requirements is also vital; while standard drums are common, nitrogen-flushed containers may be necessary to prevent oxidation during long-term storage. By aligning technical requirements with commercial expectations, buyers can streamline the negotiation process and secure supply contracts that support long-term project goals.
Technical Specifications Overview
| Parameter | Specification |
|---|---|
| Chemical Name | 2,6-Diamino-9-(β-D-arabinofuranosyl)purine |
| CAS Number | 34079-68-0 |
| Molecular Formula | C10H14N6O4 |
| Molecular Weight | 282.26 g/mol |
| Appearance | Off-white to pale yellow powder |
| Purity (HPLC) | >98.0% (Typical Industrial Grade) |
| Storage Conditions | 2-8°C Refrigerator, Sealed |
| Application | Pharmaceutical Intermediates, Research Standards |
In conclusion, navigating the bulk market for nucleoside intermediates requires a balance of technical due diligence and commercial acumen. The projected pricing landscape for 2026 favors buyers who establish long-term partnerships with capable manufacturers. NINGBO INNO PHARMCHEM CO.,LTD. remains committed to delivering consistent quality and competitive pricing structures for global clients. By prioritizing verified purity data and leveraging volume incentives, procurement teams can optimize their supply chains for successful drug development outcomes.